ExSAR has executed hundreds of studies for major pharmaceutical, biopharmaceutical and academic clients utilizing our H/D-Exchange technology platform. ExSAR offers a collaborative and consultative approach, with verbal and written presentation of results. We strictly adhere to confidentiality obligations, and typical relationships are according to simple fee-based, milestone driven terms.
We offer feasibility-based arrangements, as well as ‘bulk’ volume discounting, that encompass any of the H/D-Exchange analytical services that we offer, from epitope mapping to ligand binding studies, to structural comparisons. Scientific leadership includes Dr. Charles Cantor, Dr. William DeGrado, and Dr. S. Walter Englander, each members of the National Academy of Science. Projects are conducted under the supervision of Dr. Yoshitomo Hamuro. For additional information or to arrange a web based presentation, please contact Bob Towarnicki.